APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysine Specific Demethylase 1 Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lysine Specific Demethylase 1 Inhibitor Market Outlook and Growth Opportunities 2026

30 December 2025199 pages

Choose your research edition.

Industry ResearchLysine Specific Demethylase 1 Inhibitor Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysine Specific Demethylase 1 Inhibitor Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Lysine Specific Demethylase 1 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysine Specific Demethylase 1 Inhibitor Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysine Specific Demethylase 1 Inhibitor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lysine Specific Demethylase 1 Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lysine Specific Demethylase 1 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lysine Specific Demethylase 1 Inhibitor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lysine Specific Demethylase 1 Inhibitor market include 4SC, Beatica, Celgene Corporation, CSPC ZhongQi Pharmaceutical Technology, Oryzon Genomics, Rasna Therapeutic, Salarius Pharmaceuticals and Taiho Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lysine Specific Demethylase 1 Inhibitor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lysine Specific Demethylase 1 Inhibitor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lysine Specific Demethylase 1 Inhibitor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lysine Specific Demethylase 1 Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Lysine Specific Demethylase 1 Inhibitor Segment by Company

4SC

Beatica

Celgene Corporation

CSPC ZhongQi Pharmaceutical Technology

Oryzon Genomics

Rasna Therapeutic

Salarius Pharmaceuticals

Taiho Pharmaceutical

Lysine Specific Demethylase 1 Inhibitor Segment by Type

Vaccine

Monoclonal Antibody

Lysine Specific Demethylase 1 Inhibitor Segment by Application

Breast Cancer

Prostate Cancer

Others

Lysine Specific Demethylase 1 Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lysine Specific Demethylase 1 Inhibitor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lysine Specific Demethylase 1 Inhibitor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lysine Specific Demethylase 1 Inhibitor significant trends, drivers, influence factors in global and regions.

6. To analyze Lysine Specific Demethylase 1 Inhibitor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysine Specific Demethylase 1 Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysine Specific Demethylase 1 Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysine Specific Demethylase 1 Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lysine Specific Demethylase 1 Inhibitor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lysine Specific Demethylase 1 Inhibitor industry.

Chapter 3: Detailed analysis of Lysine Specific Demethylase 1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lysine Specific Demethylase 1 Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lysine Specific Demethylase 1 Inhibitor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lysine Specific Demethylase 1 Inhibitor Industry Trends Table 2. Lysine Specific Demethylase 1 Inhibitor Industry Drivers Table 3. Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges Table 4. Lysine Specific Demethylase 1 Inhibitor Industry Restraints Table 5. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lysine Specific Demethylase 1 Inhibitor Revenue Share by Company (2021-2026) Table 7. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Company (2021-2026) Table 9. Global Lysine Specific Demethylase 1 Inhibitor Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lysine Specific Demethylase 1 Inhibitor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lysine Specific Demethylase 1 Inhibitor Key Company Manufacturing Base & Headquarters Table 12. Global Lysine Specific Demethylase 1 Inhibitor Company, Product Type & Application Table 13. Global Lysine Specific Demethylase 1 Inhibitor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lysine Specific Demethylase 1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vaccine Table 18. Significant Companies of Monoclonal Antibody Table 19. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Type (2021-2026) Table 23. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Type (2027-2032) Table 24. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type (2021-2026) Table 28. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Breast Cancer Table 30. Significant Companies of Prostate Cancer Table 31. Significant Companies of Others Table 32. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Application (2021-2026) Table 36. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Application (2027-2032) Table 37. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application (2021-2026) Table 41. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application (2027-2032) Table 42. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2026) & (K Units) Table 44. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2021-2026) Table 45. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2027-2032) & (K Units) Table 46. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2027-2032) Table 47. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Region (2021-2026) Table 50. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Region (2027-2032) Table 52. Global Lysine Specific Demethylase 1 Inhibitor Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lysine Specific Demethylase 1 Inhibitor Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lysine Specific Demethylase 1 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 57. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2021-2026) Table 58. Global Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 59. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2027-2032) Table 60. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Market Share by Country (2021-2026) Table 62. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Market Share by Country (2027-2032) Table 64. 4SC Company Information Table 65. 4SC Business Overview Table 66. 4SC Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 68. 4SC Recent Development Table 69. Beatica Company Information Table 70. Beatica Business Overview Table 71. Beatica Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 73. Beatica Recent Development Table 74. Celgene Corporation Company Information Table 75. Celgene Corporation Business Overview Table 76. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 78. Celgene Corporation Recent Development Table 79. CSPC ZhongQi Pharmaceutical Technology Company Information Table 80. CSPC ZhongQi Pharmaceutical Technology Business Overview Table 81. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 83. CSPC ZhongQi Pharmaceutical Technology Recent Development Table 84. Oryzon Genomics Company Information Table 85. Oryzon Genomics Business Overview Table 86. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 88. Oryzon Genomics Recent Development Table 89. Rasna Therapeutic Company Information Table 90. Rasna Therapeutic Business Overview Table 91. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 93. Rasna Therapeutic Recent Development Table 94. Salarius Pharmaceuticals Company Information Table 95. Salarius Pharmaceuticals Business Overview Table 96. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 98. Salarius Pharmaceuticals Recent Development Table 99. Taiho Pharmaceutical Company Information Table 100. Taiho Pharmaceutical Business Overview Table 101. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 103. Taiho Pharmaceutical Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Lysine Specific Demethylase 1 Inhibitor Distributors List Table 107. Lysine Specific Demethylase 1 Inhibitor Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Lysine Specific Demethylase 1 Inhibitor Product Image Figure 2. Global Lysine Specific Demethylase 1 Inhibitor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lysine Specific Demethylase 1 Inhibitor Sales (2021-2032) & (K Units) Figure 5. Global Lysine Specific Demethylase 1 Inhibitor Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lysine Specific Demethylase 1 Inhibitor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vaccine Image Figure 10. Monoclonal Antibody Image Figure 11. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Type (2021-2032) Figure 14. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type (2021-2032) Figure 17. Breast Cancer Image Figure 18. Prostate Cancer Image Figure 19. Others Image Figure 20. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Application (2021-2032) Figure 23. Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application (2021-2032) Figure 26. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lysine Specific Demethylase 1 Inhibitor Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lysine Specific Demethylase 1 Inhibitor Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Monoclonal Antibody
Applications
  • Breast Cancer
  • Prostate Cancer
  • Others
Companies covered
  • 4SC
  • Beatica
  • Celgene Corporation
  • CSPC ZhongQi Pharmaceutical Technology
  • Oryzon Genomics
  • Rasna Therapeutic
  • Salarius Pharmaceuticals
  • Taiho Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  4. 1.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume (2021-2032)
  5. 1.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lysine Specific Demethylase 1 Inhibitor Market Dynamics
  1. 2.1 Lysine Specific Demethylase 1 Inhibitor Industry Trends
  2. 2.2 Lysine Specific Demethylase 1 Inhibitor Industry Drivers
  3. 2.3 Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges
  4. 2.4 Lysine Specific Demethylase 1 Inhibitor Industry Restraints
3 Lysine Specific Demethylase 1 Inhibitor Market by Company
  1. 3.1 Global Lysine Specific Demethylase 1 Inhibitor Company Revenue Ranking in 2025
  2. 3.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Company (2021-2026)
  3. 3.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Company (2021-2026)
  4. 3.4 Global Lysine Specific Demethylase 1 Inhibitor Average Price by Company (2021-2026)
  5. 3.5 Global Lysine Specific Demethylase 1 Inhibitor Company Ranking (2024-2026)
  6. 3.6 Global Lysine Specific Demethylase 1 Inhibitor Company Manufacturing Base and Headquarters
  7. 3.7 Global Lysine Specific Demethylase 1 Inhibitor Company Product Type and Application
  8. 3.8 Global Lysine Specific Demethylase 1 Inhibitor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lysine Specific Demethylase 1 Inhibitor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lysine Specific Demethylase 1 Inhibitor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lysine Specific Demethylase 1 Inhibitor Market by Type
  1. 4.1 Lysine Specific Demethylase 1 Inhibitor Type Introduction
  2. 4.1.1 Vaccine
  3. 4.1.2 Monoclonal Antibody
  4. 4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type
  5. 4.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type
  9. 4.3.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type (2021-2032)
5 Lysine Specific Demethylase 1 Inhibitor Market by Application
  1. 5.1 Lysine Specific Demethylase 1 Inhibitor Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application
  6. 5.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application
  10. 5.3.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application (2021-2032)
6 Lysine Specific Demethylase 1 Inhibitor Regional Sales and Value Analysis
  1. 6.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2032)
  3. 6.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021-2026
  4. 6.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2027-2032)
  5. 6.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Region (2027-2032)
  9. 6.5 Global Lysine Specific Demethylase 1 Inhibitor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  12. 6.6.2 North America Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  15. 6.7.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  21. 6.9.2 South America Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lysine Specific Demethylase 1 Inhibitor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Country, 2025 VS 2032
7 Lysine Specific Demethylase 1 Inhibitor Country-level Sales and Value Analysis
  1. 7.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2032)
  4. 7.3.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026)
  5. 7.3.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032)
  6. 7.4 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lysine Specific Demethylase 1 Inhibitor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC
  2. 8.1.1 4SC Company Information
  3. 8.1.2 4SC Business Overview
  4. 8.1.3 4SC Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  6. 8.1.5 4SC Recent Developments
  7. 8.2 Beatica
  8. 8.2.1 Beatica Company Information
  9. 8.2.2 Beatica Business Overview
  10. 8.2.3 Beatica Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  12. 8.2.5 Beatica Recent Developments
  13. 8.3 Celgene Corporation
  14. 8.3.1 Celgene Corporation Company Information
  15. 8.3.2 Celgene Corporation Business Overview
  16. 8.3.3 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  18. 8.3.5 Celgene Corporation Recent Developments
  19. 8.4 CSPC ZhongQi Pharmaceutical Technology
  20. 8.4.1 CSPC ZhongQi Pharmaceutical Technology Company Information
  21. 8.4.2 CSPC ZhongQi Pharmaceutical Technology Business Overview
  22. 8.4.3 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  24. 8.4.5 CSPC ZhongQi Pharmaceutical Technology Recent Developments
  25. 8.5 Oryzon Genomics
  26. 8.5.1 Oryzon Genomics Company Information
  27. 8.5.2 Oryzon Genomics Business Overview
  28. 8.5.3 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  30. 8.5.5 Oryzon Genomics Recent Developments
  31. 8.6 Rasna Therapeutic
  32. 8.6.1 Rasna Therapeutic Company Information
  33. 8.6.2 Rasna Therapeutic Business Overview
  34. 8.6.3 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  36. 8.6.5 Rasna Therapeutic Recent Developments
  37. 8.7 Salarius Pharmaceuticals
  38. 8.7.1 Salarius Pharmaceuticals Company Information
  39. 8.7.2 Salarius Pharmaceuticals Business Overview
  40. 8.7.3 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  42. 8.7.5 Salarius Pharmaceuticals Recent Developments
  43. 8.8 Taiho Pharmaceutical
  44. 8.8.1 Taiho Pharmaceutical Company Information
  45. 8.8.2 Taiho Pharmaceutical Business Overview
  46. 8.8.3 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  48. 8.8.5 Taiho Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lysine Specific Demethylase 1 Inhibitor Value Chain Analysis
  2. 9.1.1 Lysine Specific Demethylase 1 Inhibitor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lysine Specific Demethylase 1 Inhibitor Sales Mode & Process
  6. 9.2 Lysine Specific Demethylase 1 Inhibitor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lysine Specific Demethylase 1 Inhibitor Distributors
  9. 9.2.3 Lysine Specific Demethylase 1 Inhibitor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst